Alternatively spliced tissue factor promotes breast cancer growth in a β1 integrin-dependent manner
Begüm Kocatürk(Leiden University Medical Center), Henri H. Versteeg(Scripps Research Institute), Wolfram Ruf(Scripps Research Institute), J. Sven D. Mieog(Leiden University Medical Center), Gerrit‐Jan Liefers(Leiden University Medical Center), Esther M. de Kruijf(Leiden University Medical Center), Vladimir Y. Bogdanov(University of Cincinnati Medical Center), Pieter H. Reitsma, Martijn A. van der Ent, Peter J.K. Kuppen(Leiden University Medical Center), Chris Tieken, C.C. Engels(Leiden University Medical Center), Susanne Osanto, Cornelis JH van de Velde(Leiden University), Yascha W. van den Berg
Cited by 65
Related Papers
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
|Annals of Oncology|2012|1.5k
Gastric cancer
|The Lancet|2009|890
Micrometastases and Survival in Stage II Colorectal Cancer
|New England Journal of Medicine|1998|601
Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials.
|Journal of Clinical Oncology|1993|552
Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer
|Journal of Clinical Oncology|2010|540